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The demonstration that hamster (1-3) and human (2) cells  transformed by 
SV40 virus synthesize a new antigen under control of the virus genome led to 
the discovery that the same antigen is also formed during the normal replica- 
tion cycle of SV40 in green monkey cells  (3-5). As the sequence of SV40 repli- 
cation had been previously studied (6, 7), it was quickly ascertained that this 
new tumor or T  antigen is formed during the latent period and that synthesis 
of T  antigen precedes that of the virus or V antigen found in the SV40 virion 
(5). 
From our earlier investigations of the inhibitory effect of 5-fluorouracil and 
5-fluorodeoxyuridine on the synthesis of V antigen and infectious virus (7), we 
were led into a  study of the effects of these and other DNA antagonists and 
inhibitors on the synthesis of both T  and V antigens in an effort to obtain in- 
formation concerning the nature and role of the T  antigen in the synthesis of 
SV40 virus as well  as its formation in cells  transformed by the virus but free 
of infectious virions. 
Materials and Methods 
Viru*.--Stocks of SV40 were prepared in primary African green monkey kidney cells 
(GMK) growing  in 16-ounce  bottles. When cytopathic effects (CPE) involved 75 to 100 per 
cent of the cells, the cultures were disrupted by quick-freezing  and thawing. After clarifica- 
tion by centrifugation at 3000 g for 5 minutes at 4°C, the virus was dispensed in ampoules 
which were sealed; the virus was quickly frozen, and stored at --90°C. "liters of the virus 
stocks were obtained using the plaque assay previously described (8); all stocks employed in 
this study contained 108 to 10  T  plaque-forming  units (PFU) per ml. The tumorigenic potential 
of this virus strain has been reported from this laboratory (9), as has the growth cycle  of the 
virus in GMK cells (7). 
Cell Cultures.---Cuitures were prepared from African green monkey kidneys using lactal- 
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bumin hydrolysate medium  (M-H for growth and M-E for maintenance)  as described  (10). 
Growth medium contained  2 per cent calf serum; maintenance fluids did not contain serum. 
InhibiWrs.--The preparation of the inhibitors has been described (11). Stocks of 5-iodo-2'- 
deoxym'idine  (IUDR),  1-t3-D-arabinofuranosylcytosine hydrochloride  (CA),  5-fluorouracil 
(FU), 5-fluorodeoxyuridine (FUDR), actinomycin D, mitomycin C, puromycin, and p-fluoro- 
phenylalanine (FPA) were prepared by dissolving the compounds in either water or Eagle's 
basal medium at a concentration of 1 mg per ml. The stocks were refrigerated or frozen and 
protected against exposure to light. Further dilution to give the concentrations  desired was 
made directly into maintenance  medium.  The inhibitors were added to the cultures after 
virus adsorption (37°C for 1 hour) had taken place unless otherwise noted. 
Immunofluorescent Techniques.--The preparation, fractionation, and  fluorescein-labeling 
of the sera has been described (2, 7). Cells to be examined were grown on 15 mm round cover- 
glasses in Petri dishes, and inoculated with 0.1 ml of undiluted virus suspension in such a way 
that the fluid did not spill over the edge of the coverglass (12). After adsorption of the virus, 
the coverglasses were flooded with maintenance medium and incubated at 37°C in 5 per cent 
COs. The cells were harvested at times noted, washed 3 times with tris saline (pH 7.4), air- 
dried, and fixed for 3 minutes in acetone.  T antigen was detected by reacting the cells with 
serum from hamsters bearing SV40 tumors and anti-hamster globulin prepared from rabbit 
serum and conjugated with fluorescein isothiocyanate. V antigen was localized with a labeled 
monkey serum from an African green monkey  repeatedly immunized with SV40. The cells were 
washed,  air-dried, and mounted on slides in elvanol (13). The preparations were examined 
with a Zeiss fluorescence microscope equipped with an Osram HBO-200 mercury arc vapor 
lamp. 
Complement Fixation Tests.--These tests were carried out  in wells  in linbro  disposable 
plastic trays using a  micro-technique  described  previously (5).  Antigen was prepared by 
harvesting infected ceils from 16-ounce bottle cultures into a volume of 1 ml, followed by dis- 
ruption of the cells by sonication or freezing and thawing. A positive and negative serum was 
included with each test as were complement, antigen, serum, and cell controls. 
RESULTS 
Effect of Deoxyribonucleia: Acid Anlagonisls.mNone of the antagonists tested 
inhibited or delayed the synthesis of T  antigen. All compounds were tested in 
concentrations ranging from 0.1 #g per ml to 50 #g per ml added immediately 
after virus adsorption. Concentrations higher than 50 #g per ml were generally 
cytotoxic. Pretreatment of the cells with the inhibitors did not result in inhibi- 
tion of the synthesis of T  antigen.  Results of representative experiments are 
summarized in Table I. It is obvious that neither CA, IUDR, nor FU depressed 
or delayed synthesis of T  antigen as measured by complement fixation. The 
amount of T  antigen detectable in the treated cultures 24 and 48 hours post- 
inoculation was  comparable  to  that  of  the  infected,  but  drug-free,  controls. 
Similarly, the number of cells positive for T  antigen by the immunofluoreseence 
technique was similar in both untreated and treated cultures.  FUDR  yielded 
similar results in a  separate experiment but the cultures were not examined by 
complement fixation methods. 
The synthesis of V  antigen was somewhat depressed in cultures maintained 
in IUDR  or FU but a  considerable quantity of this antigen was nevertheless 
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of V antigen.  CA, however, completely inhibited synthesis of V antigen when 
measured by either complement fixation or immunofluorescence (Table I). The 
inhibitory effect of CA could be reversed by the addition of 2-deoxycytidine. 
Starved cells, maintained for 24 hours in Earle's salt solution prior to inocu- 
lation with SV40, and maintained in salt solution containing various inhibitors 
TABLE I 
Synthesis of SV40 Tumor and Virus Antigens in Monkey Kidney Cells Exposed to DNA 



















































T antigen  V antigen 
25  0 
50  0 
25  <0.1 
25  25 
Positive  Not done 
Not done  Positive 
25  Not done 
5O  5O 
25  5 
50  75 
* Titers represent reciprocal of highest dilution of antigen yielding less than 50 per cent 
hemolysis, against 1:20 hamster serum (from a tumor-bearing animal) for measuring tumor 
antigen, and against 1:40 monkey  serum (from an SV40-infected animal) for measuring virus 
antigen. 
Numbers represent approximate percentage of  cells containing respective antigens. 
CA, cytosine arabinoside; IUDR, iododeoxyuridine;  FUDR, fluorodeoxyuridine; FU, fluoro- 
uracil. 
following inoculation were  also able  to synthesize T  antigen in  the presence 
of the DNA antagonists  (Table II). Neither starved nor well  nourished cells 
formed  V  antigen  in  the  presence  of  CA.  However,  though nourished  cells 
formed V antigen in the presence of FUDR, starved cells were unable to do so 
(Table  II). This was also true for cells  maintained in  the presence of FPA. 
Starved control cells  infected with SV40  were able to synthesize both T  and 
V antigens. 
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by the presence of the inhibitors and resembles that in infected cells in the 
absence of drugs, as shown in Fig. 1. However, though V antigen was produced 
in cells maintained in the presence of FU and IUDR  (Tables I  and II), dis- 
tribution of the  antigen  in  the nucleus was  atypical, confirming results  de- 
scribed previously with FU (7). Thus, V antigen synthesized in the presence of 
FU  or IUDR  was  diffusely spread  throughout  the nucleus  (Figs.  2  and 3), 
Many cells had concentrations of V antigen at the nuclear membrane (Figs. 3 
and 4). Particulates of V  antigen observed in the nucleus of control infected 
cultures (Fig. 5) were rarely seen in cells maintained in the presence of the in- 
hibitors tested. 
TABLE II 














Nourished  cells 
T  antigen*  V a~tigen~ 
+  0 
+  + 
+  + 
+  + 
+  + 
+  + 
Stmrved cells 
T  antigen*  V antigens 
+  0 
+  + 
+  I  o 
+  I  + 
+  0 
+  + 
* Measured by immunofluorescence  24 hours following  inoculation. 
:~ Measured by immtmofluorescence  48 hours following  inoculation. 
+, Presence  of tumor antigen or virus antigen. 
0, Absence  of tumor antigen or virus antigen. 
The suspensions prepared for the complement fixation tests were examined 
in the electron microscope, after being stained with uranyl acetate (14).  1 Well 
formed virions were observed in large quantity only in control, infected cul- 
tures, but cells treated with IUDR produced virus particles which appeared 
ragged and often empty. 
All DNA antagonists tested inhibited synthesis of infectious virus. Attempts 
to isolate virus from the fluids of cultures treated with the inhibitors never 
yielded more than  traces of virus.  Furthermore, incorporating the irflaibitors 
into the agar overlay resulted in a reduction of plaque formation by SV40.  As 
little as 1/zg per ml of IUDR or CA in such a test resulted in greater than 99 per 
cent plaque inhibition (Table III). 
Effect of Antibiotics  and Protein Inhibitors.bActinomycin  D, in concentra- 
tions of 1 and 5 #g per ml, suppressed synthesis of both T  and V antigens as 
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TABLE HI 
Inhibition  of Dcvdopment  of SV40 Plaques by Iododeoxyuridine  and Cytosine Arabinoside 
Inhibitor  PFU  Inhibition 
ml  p~ c~ 
None  4.9  X  107  -- 
IUDR*  3.0  X  10  s  99.37 
CA*  1.7  X  104  99.97 
* Tested  at  i  zg per ml. 
PFU,  plaque-forming units. 
TABLE IV 
Synthesis of SV40 Tumor and  Virus Antigens in Monkey Kidney Cells Exposed  to Antibiotics 
or Protein lnhibitors for 24 to 48 Hours 
Compound 
~.ctinomycin  D 
~¢Iit  omycin C 
Puromydn 














Complement  fixation* 
T  antigen  V antigen 
Not done  Not done 
4  <2 
8  8 
32  64 
32  512 
16  128 
32  256 
32  128 
Not done  Not done 






















* Titers represent reciprocal of highest dilution of antigen yielding less than 50 per cent 
hemolysis. 
Numbers represent approximate percentage of cells containing respective antigens. 
SV40 tumor antigen measured 24 hours postinoculation. 
SV40 virus antigen measured 48 hours postinoculation. 
measured by complement fixation and immunofluorescence  methods (TableIV). 
Concentrations of  1  and  10 #g per ml of mitomycin C  were ineffective, but 
50/~g per nil suppressed synthesis of  both antigens, probably because mito- 
mycin C  at this concentration is extremely toxic to the cells for the period of 
exposure required.  Neither  puromycin nor  FPA were  inhibitory in the  con- 
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be tested because of the toxicity of the compound. Prior starvation did not 
impair  ability of the cells  to  synthesize T  antigen  in  the presence  of FPA 
(Table H) but synthesis of V antigen was inhibited (Table II). 
Distribution of both T  and V antigens in the presence of these compounds 
was generally atypical and often bizarre. T antigen,  synthesized in the presence 
of puromycin, was concentrated around the nucleolus  (Fig. 6) and often limited 
to this area.  Parallel fiber-like structures  (Fig.  7) were often seen in infected 
cells maintained in mitomycin C. Cultures maintained in FPA often included 
cells in which T antigen (Fig.  8) or V antigen (Fig. 9) was concentrated at the 
nuclear membrane. 
The cytotoxicity of the compounds when left in contact with the cells for 
24 and 48 hours made interpretation of infectious virus yields difficult;  reduced 
yields would be expected because of destruction of the ceils by the antibiotics 
tested. Comparable studies carried out with the same cell, virus, and inhibitors 
failed to reveal virus particles in infected cultures maintained in puromycin or 
actinomycin D  whereas particles forming in the presence of FPA were hollow 
and appeared to be devoid of DNA (15). 
DISCUSSION 
The  inhibition  of  the  development  of  DNA-containing  viruses  by DNA 
antagonists and by antibiotics represents a useful approach for the study of the 
molecular events involved in the synthesis of virus components and infectious 
virions.  The compounds used in this study are known to exert different effects 
on the  synthesis of DNA, RNA,  and  protein.  Knowledge of their  mode of 
action coupled with the observations made in this study yields insight into the 
steps  involved in  the  development of SV40  components and  the infectious 
virion. 
The  inhibition  of  the  development  of  infectious  SV40  by various  DNA 
antagonists is not surprising  since  previous studies had shown that  FU and 
FUDR (7) as well as IUDR (16,  17) depress virus synthesis. Analysis  of the 
inhibitory effects of the compounds used and ability to detect early antigens 
formed during the replicative cycle of SV40 sheds new light,  however, on the 
steps  affected in  viral  replication.  Text-fig.  1 diagrammatically  summarizes 
both the sequence of events leading to formation of SV40 in green  monkey 
kidney cells as well as the location of the biochemical  block by actinomycin D 
and by the DNA antagonists. 
Actinomycin D  is the only compound tested capable of inhibiting synthesis 
of T antigen, and all the later events of the repilcative cycle. Formation of T 
antigen  therefore presumably requires  DNA-dependent RNA (18).  The syn- 
thesis of T antigen (step 2) is not inhibited by CA, FU, IUDR, or FUDR. As 
these compounds either  block development  of DNA  (19,  20)  or  allow  only 
faulty DNA synthesis  (21),  the formation  of T  antigen  does not appear  to RAPP,  BUTEL,  FELDMAN~ I~TTA~  AND MELNICK  941 
require replication of virus DNA. The results with mitomycin C (at 10 #g/ml) 
would appear to support this assumption since this compound cross-finks  the 
strands of DNA and thus inhibits replication (22). Ability of the cells to form 
T antigen in the presence of puromycin suggests that the antigen is a low molec- 
ular weight protein, or even a small polypeptide. This conclusion is suggested 
by recent studies which demonstrated that the action of puromycin is through 
its attachment to the incomplete polypeptide chain by substituting for amino 
acyl sRNA, thus preventing additional peptide bonds from forming (23,  24). 
The view that T  antigen is a low molecular weight compound has previously 
been hypothesized based on inability to sediment the antigen by high  speed 
centrifugation (1, 4, 5).  The concentration of T antigen at the nucleolar mem- 
SEQUENTIAL INHIBITION OF  STEPS IN THE  SV40 REPLICATION CYCLE 
ACTINOMYCIN D  CYTOSINE  FLUOROURACIL  IODODEOXYURIDINE 
ARABINOSIDE 
l  l 
MONKEY  TUMOR  Vl RUS  VIRUS  MATURATION 
CELL  ANTIGEN  ANTIGEN  PARTICLES 
O)  (2)  (3)  (4)  (5) 
T~XT-FIG.  1.  Diagrammatic representation  of sequential  steps in the synthesis of SV40 
and the site of action of each inhibitor. 
brane when synthesized in the presence of puromycin suggests that the nucleo- 
]us plays a role in the formation of this antigen. Since under the usual conditions 
of infection T  antigen is not concentrated in this region, puromycin may also 
act  by inhibiting  an active transport  mechanism. 
Although both FU and IUDR allow synthesis of T and V antigens, infectious 
virions do not develop. Previous observations concerning  the effect of FU on 
the synthesis of SV40 had  revealed that  virus particles did not form in the 
presence  of the inhibitor  (7)  and  these  results  were verified  in  the present 
study. IUDR, however, does allow  the formation of particles, although  they 
are non-infectious.  This finding  is similar  to that made by Smith and Dukes 
(25) for herpes simplex virus; herpes zoster virus antigens are also synthesized 
in the presence of IIYDR  (26). 
The failure  of cells  exposed to  CA  to synthesize V  antigen  confirms  pre- 
liminary observations from this laboratory (17, 27). In this respect, the action 942  SV40 TUMOR  AND  VIRUS  ANTIGENS 
of CA is similar to that of FUDR in starved cells. However, failure of FUDR 
to inhibit synthesis of V antigen in well nourished ceils supports the conclusion 
that CA acts at a different locus. It is possible that the inhibitory effect of CA 
in this system involves more than one site, a conclusion also supported by the 
observation that this compound interferes with enzymes not involved in DNA 
synthesis (20). 
The  recent  finding that  some  adenovirions  can  incorporate  a  portion  of 
SV40  genome (28-30)  which is expressed by induction in susceptible ceils of 
the synthesis of SV40 T  antigen (but not V antigen) makes available an addi- 
tional system for study of the synthesis of T antigen. Preliminary experiments 
in our laboratory suggest that the effects of the compounds described in this 
study on the synthesis of T antigen induced by the adenovirus-SV40 "hybrids" 
resemble those seen when T  antigen is induced by SV40. 
SUM'MARY 
The effect of DNA antagonists and various antibiotics on steps in the syn- 
thesis of SV40 virus in green monkey kidney cells was investigated. Both the 
early forming tumor (T)  antigen, as well as the later synthesized virus  (V) 
antigen, were synthesized in the presence of fluorouracil and iododeoxyuridine. 
Cytosine  arabinoside  (and  fluorodeoxyuridine  in  starved  ceils)  prevented 
synthesis of V antigen but not T antigen. The synthesis of T antigen therefore 
does not require synthesis of virus DNA.  Virus particles formed only in the 
presence of the iododeoxynridine and they were non-infectious. 
Actinomycin D  inhibited synthesis of both tumor and virus antigens, sug- 
gesting that the synthesis of these antigens involves DNA-dependent RNA. 
Puromycin allowed synthesis of the T antigen which remained localized at the 
nucleolar membrane. This finding with puromycin suggests that the T  antigen 
is a protein of low molecular weight. Virus antigen forming in the presence of 
mitomycin  C,  p-fluorophenylalanine, iododeoxyuridine,  or  fluorouracil  was 
distributed atypically. These inhibitors caused the V  antigen to be diffusely 
spread throughout the nucleus, or to be concentrated at the nuclear membrane. 
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EXPLANATION  OF PLATES 
PLATE 74 
FIGS. I to 5. Immunofluorescence  photomicrographs  of green monkey kidney cells 
following  inoculation  with SV40. 
FIG. 1. Cultures maintained in the absence of drugs.  Reacted 24 hours following 
inoculation  with anti-T antigen reagents.  Arrows point to cells containing intranu- 
clear T  antigen.  ×  360. 
FIG. 2. Cultures maintained in 10 ~g of fluorouracil per ml. Reacted 48 hours fol- 
lowing  inoculation  with  anti-V  antigen  reagents.  V  antigen  distributed  diffusely 
throughout nucleus.  ×  1440. 
FIGS. 3 and 4. Cultures maintained in 50 and 10/~g of iododeoxyuridine per ml re- 
spectively.  Reacted  48  hours  following inoculation  with  anti-V  antigen  reagents. 
Especially note concentration of V antigen at nuclear periphery. ×  360. 
FIG. 5. No drugs. Reacted 48 hours following inoculation  with anti-V antigen re- 
agents.  V antigen distributed in particulates in the nuclei.  ×  360. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL  121  PLATE  74 
(Rapp et a/.: SV40 tumor and virus antigens) PLATE 75 
FIGS. 6 to 9. Immunofluorescence photomicrographs of green monkey kidney cells 
following inoculation with  SV40. 
FIG. 6. Culture maintained in 1 #g of puromycin per ml. Reacted with anti-T anti- 
gen reagents 24 hours following inoculation. T  antigen concentrated around nucleoli. 
×  380. 
FIG.  7.  Culture maintained in  1 #g of mitomycin C per ml. Reacted with anti-T 
antigen reagents 24 hours following inoculation. Note parallel fiber-like intranuclear 
structures reacting with anti-T reagents.  ×  380. 
FIGS.  8  and  9.  Cultures  maintained  in  500  ~g  of  p-fluorophenylalanine per  ml. 
×  380.  Fig. 8.  Reacted  with  anti-T antigen reagents.  Fig. 9.  Reacted  with  anti-V 
antigen reagents. Note concentration of antigens at nuclear membrane. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL  121  PLATE  75 
(Rapp eta/.: SV40 tumor and virus antigens) 